{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-24-000245","form_type":"8-K","ticker":"HLF","cik":"0001180262","company_name":"HERBALIFE LTD.","filed_at":"2024-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.580127+00:00","generated_at":"2026-06-06T02:05:42.500891+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Herbalife Q4 net sales up 2.9% YoY to $1.2B; full-year net sales down 2.7% to $5.1B; initiates refinancing of 2018 loans","bullets":["Q4 net sales $1.2B, up 2.9% YoY (2.5% constant currency); net income $10.2M, diluted EPS $0.10.","Full-year 2023 net sales $5.1B, down 2.7% vs 2022; net income $142.2M, diluted EPS $1.42, adjusted EPS $2.21.","Adjusted EBITDA Q4 $108.8M, full-year $570.6M; free cash flow $222.5M, operating cash flow $357.5M.","Transformation Program cost savings of ~$70M realized in 2023; pre-tax expenses ~$12M in Q4.","Refinancing initiated for 2018 Term Loan A and Revolving Credit Facility (due March 2025); Annual Meeting April 25, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-24-000245","json":"https://secwatch.observer/filing/0001157523-24-000245.json","markdown":"https://secwatch.observer/filing/0001157523-24-000245.md","text":"https://secwatch.observer/filing/0001157523-24-000245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1180262/000115752324000245/0001157523-24-000245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1180262/000115752324000245/a53896295.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T02:05:42.500891+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8e172c3a8125fd98b2c9b4215919034f6738478e","claim":"HERBALIFE LTD. reported fourth fiscal quarter and fiscal year ended December 31, 2023 results: revenue $1.2 billion, net income $10.2 million, EPS $0.10.","evidence_excerpt":"year-over-year net sales growth on both reported and constant currency basis 1 Fourth consecutive quarter of improved year-over-year reported net sales trends Net sales of $1.2 billion, up 2.9% vs. 4Q ‘22; on constant currency basis 1 , net sales increased 2.5% vs. 4Q ‘22 Net income of $10.2 million and adjusted EBITDA 2 of $108.8 million Diluted EPS of $0.10","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1180262/000115752324000245/0001157523-24-000245-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth fiscal quarter and fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$1.2 billion"},{"label":"Net income","value":"$10.2 million"},{"label":"EPS","value":"$0.10"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}